Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1490311

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1490311

Wound Biologics Market, By Product, By Wound Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

PUBLISHED:
PAGES: 301 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Wound Biologics Market size was valued at USD 1,915.2 Million in 2023, expanding at a CAGR of 12.30% from 2024 to 2032.

Wound biologics are bioengineered items designed to treat non-healing lower extremity wounds. Wound biologics covers all stages of wound treatment. This includes evaluating the wound type, identifying factors that influence wound healing, and administering the proper wound care therapy. Wound biologics address each stage of wound treatment. This includes recognizing the type of wound, determining the factors that influence wound healing, and applying the proper wound care therapy. After evaluating the wound and reviewing all requirements, the treatment center can choose the best treatment options.

Wound Biologics Market- Market Dynamics

Increase in Prevalence of Chronic Wounds Drives Market Growth

The increasing prevalence of a sedentary lifestyle, poor eating habits, and worsening chronic conditions like obesity and diabetes are significant contributors to the development of chronic wounds. Treating chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers is a costly challenge for healthcare systems due to the difficulty and expense involved in the healing process. Therefore, there is a growing demand for quick wound healing due to the rising number of patients with diabetes and obesity. In 2019, the International Diabetes Federation (IDF) reported 463 million individuals worldwide had diabetes, a figure projected to rise to 700 million by 2045. These factors are expected to drive the need for wound biologics during the projected period.

Wound Biologics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.30% over the forecast period (2024-2032)

Based on Product segmentation, Biological Skin Substitutes was predicted to show maximum market share in the year 2023

Based on Wound Type segmentation, Ulcers was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Wound Biologics Market- Segmentation Analysis:

The Global Wound Biologics Market is segmented on the basis of Product, Wound Type, End-User, and Region.

The market is divided into three categories based on Product: Biological Skin Substitutes and Topical Agents. The biological skin substitutes segment is the largest contributor to the market and is predicted to expand during the forecast period. The structural underpinning for these artificial skins comes from a healthy cellular matrix. Cadaver allografts, amnion, and porcine skin xenografts are among the most popular natural skin substitutes. Burn sufferers, those involved in vehicle accidents, and those suffering from chronic wounds such as diabetic foot or venous leg ulcers are excellent candidates for biological skin substitutes. Treatments that promote rapid wound healing and reduce symptoms in the elderly are in high demand due to the increasing prevalence of these diseases and the large older population.

The market is divided into two categories based on Wound Type: Ulcers, Burns and Surgical & Traumatic Wounds. The ulcers category is the largest contributor to the market and is predicted to expand over the forecast period. Ulcers are expected to be the most profitable sub-segment of the wound care industry due to the growing use of wound care biologics to treat ulcers and burn injuries. Biological dressings prevent water, heat, protein, and electrolyte loss, as well as contamination. Biologics used in wound treatment have been found to speed up wound closure and improve healing conditions. Forced quarantine, as well as labor and raw material shortages, have seriously affected the supply of crucial materials. Transporting raw materials from one location to another is problematic due to inadequate connections between regional warehouses.

Wound Biologics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America dominates the wound biologics market in terms of revenue due to its well-developed infrastructure, the presence of significant key players, the rise in chronic illness prevalence, and the availability of qualified medical professionals. Furthermore, the region's increased number of sports injuries and road accidents, as well as the incidence of chronic wounds, drive demand for wound care biologics solutions for road accidents and sports injuries.

Asia Pacific is emerging as the world's fastest-growing wound biologics market. The region's expansion is driven by rising healthcare spending, a huge patient population, and increased knowledge of sophisticated wound treatment solutions. Furthermore, the rapid growth of healthcare facilities, as well as the increasing use of technologically advanced wound care products in countries such as India and China, are boosting demand for wound biologics in Asia Pacific.

Wound Biologics Market- Competitive Landscape:

The global wound biologics market is extremely competitive with several significant competitors contending for market share. These companies focus on research and development in order to deliver breakthrough biologic wound care treatments that address a wide range of wound types and patient demands. Strategic collaborations, partnerships, and mergers and acquisitions are taking place in the market as companies look to extend their product portfolios and increase their market presence. Companies are also engaging in marketing and promotional operations to raise awareness among healthcare professionals and patients about the benefits of wound care biologics. The market is also seeing the introduction of new firms, which intensifies competition. Aside from established corporations, the wound biologics industry is competitive due to the presence of numerous small and medium-sized enterprises.

Recent Developments:

In April 2019, Smith & Nephew PLC acquired Osiris Therapeutics, Inc. to speed the development of its advanced wound management product portfolio. The effort was expected to increase its consumer base.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL WOUND BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Acelity L.P. Inc. (KCI) - US

Smith & Nephew plc - UK

Molnlycke Health Care AB - Sweden

Integra LifeSciences Corporation - US

Organogenesis Inc. - US

Stryker Corporation - US

Osiris Therapeutics, Inc. - US

ACell, Inc. - US

Vericel Corporation - US

Coloplast Group - Denmark

Medline Industries, Inc. - US

ConvaTec Group Plc - United Kingdom

Ethicon, Inc. (a subsidiary of Johnson & Johnson) - US

Anika Therapeutics, Inc. - US

Kerecis - Iceland

3M Company - US

Baxter International Inc. - US

Johnson & Johnson - US

MiMedx Group, Inc. - US

Solsys Medical - US

Others

GLOBAL WOUND BIOLOGICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Biological Skin Substitutes
  • Human Donor Tissue-derived Products
  • Acellular Animal-derived Products
  • Biosynthetic Products
  • Topical Agents

GLOBAL WOUND BIOLOGICS MARKET, BY WOUND TYPE- MARKET ANALYSIS, 2019 - 2032

  • Ulcers
  • Diabetic Foot Ulcers
  • Venous Ulcers
  • Pressure Ulcers
  • Other Ulcers
  • Burns
  • Surgical & Traumatic Wounds

GLOBAL WOUND BIOLOGICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Burn Centers

GLOBAL WOUND BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV2885

Table of Contents

1.Wound Biologics Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Wound Biologics Market Snippet by Product
    • 2.1.2.Wound Biologics Market Snippet by Wound Type
    • 2.1.3.Wound Biologics Market Snippet by End-User
    • 2.1.4.Wound Biologics Market Snippet by Country
    • 2.1.5.Wound Biologics Market Snippet by Region
  • 2.2.Competitive Insights

3.Wound Biologics Key Market Trends

  • 3.1.Wound Biologics Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Wound Biologics Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Wound Biologics Market Opportunities
  • 3.4.Wound Biologics Market Future Trends

4.Wound Biologics Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Wound Biologics Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Wound Biologics Market Landscape

  • 6.1.Wound Biologics Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Wound Biologics Market - By Product

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2.Biological Skin Substitutes
      • 7.1.2.1.Human Donor Tissue-derived Products
      • 7.1.2.2.Acellular Animal-derived Products
      • 7.1.2.3.Biosynthetic Products
    • 7.1.3.Topical Agents

8.Wound Biologics Market - By Wound Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Wound Type, 2023 & 2032 (%)
    • 8.1.2.Ulcers
      • 8.1.2.1.Diabetic Foot Ulcers
      • 8.1.2.2.Venous Ulcers
      • 8.1.2.3.Pressure Ulcers
      • 8.1.2.4.Other Ulcers
    • 8.1.3.Burns
    • 8.1.4.Surgical & Traumatic Wounds

9.Wound Biologics Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Biological Skin Substitutes
    • 9.1.3.Human Donor Tissue-derived Products
    • 9.1.4.Acellular Animal-derived Products
    • 9.1.5.Biosynthetic Products
    • 9.1.6.Topical Agents

10.Wound Biologics Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Wound Biologics Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Wound Biologics Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Wound Biologics Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Wound Biologics Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Wound Biologics Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Wound Biologics Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Acelity L.P. Inc. (KCI) - US
    • 11.2.2.Smith & Nephew plc - UK
    • 11.2.3.Molnlycke Health Care AB - Sweden
    • 11.2.4.Integra LifeSciences Corporation - US
    • 11.2.5.Organogenesis Inc. - US
    • 11.2.6.Stryker Corporation - US
    • 11.2.7.Osiris Therapeutics, Inc. - US
    • 11.2.8.ACell, Inc. - US
    • 11.2.9.Vericel Corporation - US
    • 11.2.10.Coloplast Group - Denmark
    • 11.2.11.Medline Industries, Inc. - US
    • 11.2.12.ConvaTec Group Plc - United Kingdom
    • 11.2.13.Ethicon, Inc. (a subsidiary of Johnson & Johnson) - US
    • 11.2.14.Anika Therapeutics, Inc. - US
    • 11.2.15.Kerecis - Iceland
    • 11.2.16. 3M Company - US
    • 11.2.17.Baxter International Inc. - US
    • 11.2.18.Johnson & Johnson - US
    • 11.2.19.MiMedx Group, Inc. - US
    • 11.2.20.Solsys Medical - US
    • 11.2.21.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us
Product Code: ANV2885

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Wound Biologics Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Wound Biologics Market, by Product 2019-2032 (USD Million)
  • TABLE Wound Biologics Market: Wound Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Wound Type
  • TABLE Global Wound Biologics Market, by Wound Type 2019-2032 (USD Million)
  • TABLE Wound Biologics Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Wound Biologics Market, by End-User 2019-2032 (USD Million)
  • TABLE Wound Biologics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Wound Biologics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Wound Biologics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Wound Biologics Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Wound Biologics Market, by Wound Type, 2019-2032 (USD Million)
  • TABLE North America Wound Biologics Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Wound Biologics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Wound Biologics Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Wound Biologics Market, by Wound Type, 2019-2032 (USD Million)
  • TABLE Europe Wound Biologics Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Wound Biologics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Wound Biologics Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Wound Biologics Market, by Wound Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Wound Biologics Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Wound Biologics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Wound Biologics Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Wound Biologics Market, by Wound Type, 2019-2032 (USD Million)
  • TABLE Latin America Wound Biologics Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Wound Biologics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Wound Biologics Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Wound Biologics Market, by Wound Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Wound Biologics Market, by End-User, 2019-2032 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!